19 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... tuberculosis infection (TB ... Infections #OIs #HIVAIDS ... #IDSA #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... tuberculosis infection (TB ... Infections #OIs #HIVAIDS ... #IDSA #management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
Factors to be considered in deciding to initiate treatment empirically for active tuberculosis (TB) (prior to
deciding to initiate treatment ... tuberculosis (TB ... ) (prior to microbiologic ... tuberculosis #initiation #management ... #IDSA
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Please refer to the table ... #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculin skin test ... staining, NAA (PCR ... Tuberculosis Treatment ... #Diagnosis #Management ... #Treatment #ActiveTB
Psittacosis 
Pathogen: Chlamydia psittaci - obligate intracellular gram negative
Transmission:
 • Birds are the primary reservoir
 •
Microimmunofluorescent antibody test ... • PCR • Culture ... first line of treatment ... Chlamydia #psittaci #microbiology ... #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculin skin test ... staining, NAA (PCR ... Tuberculosis Treatment ... #Diagnosis #Management ... #Treatment #ActiveTB
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... #infections #HIVAIDS
Helicobacter Pylori (H. pylori) Infection - Diagnosis and Management - GrepMed Handbook
Presentation: Dyspepsia / Peptic Ulcer
Diagnosis and Management ... developed countries Microbiology ... flagyl 500mg TID if PCN-allergy ... Ag, Urea Breath Test ... #Treatment #quadruple